Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New Press Release - Theralase(R) Grants Stock Options

<< Previous

Bullboard Posts

Next >>

Comment by toade1313on Sep 21, 2023 7:56pm

379 Views

Post# 35648435

RE:RE:New Press Release - Theralase(R) Grants Stock Options

Until the stock price actually goes much higher, imho they need to earn the options not just automatically be granted them. Obviously this is a minority view or they wouldn't have already been granted.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market